A study led by Todd Korthuis, M.D., that found Oregon has a 35% shortage in substance use disorder outpatient treatment facilities, a 60% shortage for inpatient treatment, and a 27% shortage for residential detox facilities, is cited in story about what Measure 110 does/does not pay for.

A study led by Todd Korthuis, M.D., that found Oregon has a 35% shortage in substance use disorder outpatient treatment facilities, a 60% shortage for inpatient treatment, and a 27% shortage for residential detox facilities, is cited in story about what Measure 110 does/does not pay for.

For Heart Month, Public News Service interviews Anthony Muholland, M.N., RN, NE-B, about managing heart failure; he says: "Limiting sodium intake to 1,500 milligrams per day or less, limiting fluid intake because fluid retention is a challenge with these patients, monitoring your blood pressure and knowing what your numbers are after you’ve talked about them with your doctor."

Craigan Usher, M.D., discusses the national Adderall shortage and how it's affecting patients in Oregon who rely on the medication to manage symptoms related to attention-deficit/hyperactivity disorder.

Tori Roloff, wife of "Little People Big World" star Zach Roloff share appreciation for OHSU clinical team via social media: "Thank you endlessly to the staff of OHSU for helping @zrollof07 through this entire experience. They were exceptional and we are so grateful to them."

Jamie Lo, M.D., comments on a study that found pregnant women diagnosed with chronic hypertension and diabetes appeared to avoid poorer outcomes if they maintained a blood pressure below some current guidelines: "I think that Dr. Harper's study suggests we should consider a different blood pressure range for our diabetic pregnant individuals. Larger randomized control trials would be needed to better assess this."

The Dark Report, an industry publication for laboratories and pathology groups, reports that organizations charged with inspecting, surveying and accrediting medical labs are facing recruitment and hiring challenges similar to the clinical labs they're tasked with inspecting, surveying and accrediting. Mick Scanlan, M.D., who also serves on the College of American Pathologists board of governors, says that although the organization has felt pressure to ensure it has enough inspectors, it has been able to fill any gaps: "We're not in crisis at the CAP for inspectors."

"Quotable quotes heard by MedPage Today's reporters," includes a comment by McConnell on the substantial regional variation among Medicaid enrollees' emergency department visits for mental health conditions: "The question is, if they did something to increase their availability of outpatient mental health [care], would you see ED visits drop?"

Michael Cohen, Ph.D., and colleagues have uncovered a new class of PARP-1 inhibitors with unique and powerful anticancer properties that could make them more widely effective. The discovery could improve both treatment for a variety of cancers and quality of life for patients; he says, "“We think it’s going to open up therapeutic possibilities beyond what current PARP-1 inhibitors are used for."

During a public hearing this week, members of the Senate Committee on Health Care discussed SB 469, which would create an Indian Health Scholarship Program, administered by OHSU, to fund the full cost of tuition for members of federally recognized enrolled in health care professional training programs.